Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00998127 · ClinicalTrials.gov registry record
Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 5,031
- Enrollment target
NCT00998127: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT00998127 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 5,031 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00998127 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 5,031 participants
- Enrollment target
Study Summary
The purpose of this observational research study is to determine when and why patients discontinue, interrupt, or disrupt the regimen of anti-platelet medications prescribed following stent implantation, and to examine the relationship between specific patterns of non-adherence and patient outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,031 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-03 |
What the finished NCT00998127 record still lists
NCT00998127 is an observational study that tracks outcomes without assigning an intervention. Its 5,031 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00998127 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00998127 about?
NCT00998127 is a clinical study titled "Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients". The purpose of this observational research study is to determine when and why patients discontinue, interrupt, or disrupt the regimen of anti-platelet medications prescribed following stent implantation, and to examine the relationship between specific patterns of non-adherence and patient outcomes.
What is the current status of trial NCT00998127?
This trial is currently completed. The enrollment target is 5,031 participants. The study started on 2009-06. Estimated completion is 2013-03.
Who is sponsoring clinical trial NCT00998127?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743362 · 5,010 participants
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
- NCT07037459 · 5,056 participants · Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia